Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Human gene therapy·2026

Same author

Impaired glycoRNA biogenesis in metabolic-dysfunction associated steatotic liver disease.

Journal of hepatology·2026

Same author

In vivo base editing alleviates hepatic iron accumulation and fibrosis in models of HFE-related hereditary hemochromatosis.

Journal of hepatology·2026

Same author

Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells.

Bone marrow transplantation·2026

Same author

Development and early feasibility testing of machine-learning algorithms to non-invasively assess hemoglobin levels.

npj biomedical innovations·2026

Same author

Functional inactivation of MDR3 caused by a homozygous <i>ABCB4</i> missense variant leading to liver failure.

Frontiers in genetics·2026

Search research articles

Related Experiment Video

Updated: May 19, 2026

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension

Published on: March 1, 2024

Engineered MSCs from Patient-Specific iPS Cells.

Irina Eberle¹, Mohsen Moslem, Reinhard Henschler

¹Junior Research Group Stem Cell Biology, OE 8881, Cluster-of-Excellence REBIRTH, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Advances in Biochemical Engineering/Biotechnology

|August 24, 2012

Summary

Mesenchymal stem cells (MSCs) show therapeutic potential in gastroenterology. Engineering MSCs or using induced pluripotent stem cells (iPSCs) may enhance their regenerative and anti-inflammatory effects for advanced cell therapies.

More Related Videos

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Published on: June 9, 2020

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Published on: October 31, 2012

Related Experiment Videos

Last Updated: May 19, 2026

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension

Published on: March 1, 2024

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Published on: June 9, 2020

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Published on: October 31, 2012

Area of Science:

Regenerative Medicine
Gastroenterology
Cell Therapy

Background:

Mesenchymal stem cells (MSCs) are a diverse cell population with therapeutic potential.
MSCs may stimulate regeneration and reduce inflammation, relevant for diseases like inflammatory bowel disease and liver failure.
MSC efficacy is influenced by source, culture, and administration, necessitating further research.

Purpose of the Study:

To review current findings on MSC applications in gastroenterology.
To explore the potential of engineered MSCs and induced pluripotent stem cells (iPSCs) for enhanced cell therapies.
To discuss the generation of patient-derived iPSCs for advanced therapeutic strategies.

Main Methods:

Literature review of pre-clinical and clinical studies on MSCs in gastroenterology.
Analysis of molecular pathways involved in MSC function.
Overview of iPSC generation and genetic engineering techniques.

Main Results:

MSCs demonstrate promise in treating various gastrointestinal and liver conditions.
MSC source, culture, and administration critically impact therapeutic outcomes.
Engineered MSCs and iPSCs offer potential for 'superfunctional' cells with improved efficacy.

Conclusions:

Optimizing MSC therapy requires careful consideration of cell source and handling.
Genetically engineered MSCs and iPSCs represent a promising frontier for advanced cell-based therapies in gastroenterology.
Patient-derived iPSCs may enable personalized and enhanced regenerative treatments.